340B Drug Pricing Program
The House Energy and Commerce Subcommittee on Health today hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.”
The AHA has submitted a statement for the hearing and issued a Member Advisory containing several resources to assist hospitals and health systems in discussing these issues.
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law.
New administrative process begins on 340B rebate models; hospitals should begin working on comment letters now.
The Department of Health and Human Services today in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart the administrative process for such a program.
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart the administrative process for such a program.
Blog: 340B is a Solution, not a Threat to Health Care Affordability
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and bipartisan health care challenges.
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.
Congress has passed the Consolidated Appropriations Act of 2026 (H.R.7148), which consists of a short-term continuing resolution for the Department of Homeland Security (DHS) appropriations bill and a package of five full-year appropriations bills, containing conferenced legislation for the…
- Legislation and Legislative Advocacy
- Medicaid
- Medicare
- Medicare Sequestration Payment Reductions
- Cybersecurity
- Rural issues
- Workforce
- Child and Adolescent Health
- Maternal Health
- Medical Education and Research
- Access to Behavioral Health
- Substance Use Disorder
- Disaster Preparedness
- 340B Drug Pricing Program